Loading organizations...
Key people at Biospring Partners.
Biospring Partners was founded in 2020 by Michelle Detwiler (Co-Founder and Managing Partner) and Jennifer Lum (Co-Founder & Managing Partner).
Biospring Partners functions as a dedicated growth buyout firm, exclusively targeting the pharma services sector. It invests in technology-enabled, EBITDA-positive business-to-business companies that optimize the clinical trial workflow. The firm modernizes processes like site operations and patient recruitment through strategic capital and operational support.
Managing Partners Michelle Detwiler, MD, PhD, and Jennifer Lum lead the firm, leveraging expertise from life sciences and technology. Their collective insight identified an opportunity for focused investment to drive innovation and efficiency across the pharma services landscape. This leadership guides acquisitions, aiming to accelerate critical support functions.
The firm's portfolio provides essential, technologically advanced services to pharmaceutical, biotechnology, and medical device clients. Biospring Partners aims to foster robust, efficient support for drug development. Its mission is to elevate the life sciences ecosystem by empowering companies delivering vital services.
Key people at Biospring Partners.
Biospring Partners was founded in 2020 by Michelle Detwiler (Co-Founder and Managing Partner) and Jennifer Lum (Co-Founder & Managing Partner).
Biospring Partners has 3 tracked investments across 3 companies. The latest tracked deal is $5.0M Seed in Patented.ai in June 2023.
